PERNUVI — 1936382
Application number
1936382
Registration number
TMA1122673
Type(s)
Word
Category
Trademark
CIPO Status
REGISTERED
TM5 status
LIVE/REGISTRATION/Issued
and Active
The trademark application has been registered with the Office.
Filed
2018-12-17
Registered
2022-03-10
Registration Expiry Date
2032-03-10
Registered Owner
Teva Pharmaceutical Industries Ltd.
124 Dvora HaNevi'a
6944020 Tel Aviv-Jaffa
ISRAEL
Agent
OSLER, HOSKIN & HARCOURT LLP
Suite 320, World Exchange Plaza
100 Queen Street
Ottawa,
ONTARIO K1P1J9
Documents
Index headings
- PERNUVI
Goods (Nice class & Statement)
- 5
- (1) Pharmaceutical preparations for the treatment of migraines.
Claims
- Proposed Use in CANADA
Recordals (known also as Footnotes)
Owner Address Change / Changement d'adresse du propriétaire DATE REGISTERED / DATE DE L'ENREGISTREMENT: 2022-02-28 COMMENTS / COMMENTAIRES: Voir Preuve au dossier/See evidence on File No. 2121983Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2018-12-17 | ||
| Created | 2018-12-17 | ||
| Formalized | 2018-12-21 | ||
| Clerical Correction | 2019-01-15 | Clerical correction / Voir Preuve au dossier/See evidence on File No. 1936382 | |
| Search Recorded | 2021-10-08 | ||
| Approved | 2021-10-15 | APPROVED BY PROGRAM EX200M1 | |
| Approval Notice Sent | 2021-10-15 | APPROVED BY PROGRAM EX200M1 | |
| Advertised | 2021-11-10 | Vol.68 Issue 3498 | |
| Amendment to Application | 2022-02-28 | Owner Address Change / Voir Preuve au dossier/See evidence on File No. 2121983 | |
| Registration Pending | 2022-03-02 | ||
| Registration Fee Notice Sent | 2022-03-02 | 2022-09-02 | |
| Registered | 2022-03-10 | 2032-03-10 |